Your browser doesn't support javascript.
loading
Introducing AgNPs-VB2 composites as the dual signal quenching of CeO2-AuNPs-g-CNQDs hybrids for ultrasensitive "on-off" electrochemiluminescence immunosensing of prostate specific antigen.
Liu, Zhimin; Wang, Jie; Cui, Chen; Zheng, Limei; Hu, Leqian.
Affiliation
  • Liu Z; College of Chemistry and Chemical Engineering, Henan University of Technology, Zhengzhou, 450001, China. Electronic address: zhimin@haut.edu.cn.
  • Wang J; College of Chemistry and Chemical Engineering, Henan University of Technology, Zhengzhou, 450001, China.
  • Cui C; College of Chemistry and Chemical Engineering, Henan University of Technology, Zhengzhou, 450001, China.
  • Zheng L; College of Chemistry and Chemical Engineering, Henan University of Technology, Zhengzhou, 450001, China.
  • Hu L; College of Chemistry and Chemical Engineering, Henan University of Technology, Zhengzhou, 450001, China.
Talanta ; 252: 123886, 2023 Jan 15.
Article in En | MEDLINE | ID: mdl-36055078
ABSTRACT
An ultrasensitive resonance energy transfer based "on-off" switch electrochemiluminescence (ECL) immunosensing strategy was proposed and applied for prostate specific antigen (PSA) detection. In detail, self-enhancing nanohybrids of nano-CeO2 and AuNPs decorated graphitic carbon nitride quantum dots (CeO2-AuNPs-g-CNQDs) were synthesized, which produced high ECL emission with coreactant K2S2O8 for "switch-on" state. Noticeably, due to the reversible Ce3+↔ Ce4+ reaction, nano-CeO2 could serve as highly-efficient coreaction accelerator and induce the decomposition of S2O82- into SO4• -, which endowed the g-CNQDs/K2S2O8 system with enhanced ECL emission. Moreover, AuNPs acted crucial role in promoting the electronic transmission rate and providing sites to immobilize the biomolecules. On the other hand, the AgNPs-VB2 nanocomposites were used as dual labels to quench the ECL signal of g-CNQDs-K2S2O8 system via ECL-RET, leading to the decreased ECL for "switch-off" state. On the basis of sandwich-typed immunosensing strategy, the developed ECL immunosensing platform exhibited sensitive response to PSA in a linear range of 1.0 × 10-5 _ 50 ng mL-1 with a low detection limit of 0.0045 pg mL-1 (S/N = 3). This work provided a promising tool in early clinical diagnostics of prostate cancer.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biosensing Techniques / Metal Nanoparticles Limits: Humans / Male Language: En Journal: Talanta Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biosensing Techniques / Metal Nanoparticles Limits: Humans / Male Language: En Journal: Talanta Year: 2023 Document type: Article